Skip to Main Content

Cellectis

Cellectis develops CAR T-cell therapies using gene editing technologies like TALEN®, creating customizable, off-the-shelf immune treatments for various cancers.

Site Profile
Security Setup
CMissing 3 of 7 security checks
  • No HSTS
  • No X-Content-Type
  • No Referrer-Policy

Passing

SSL certificate · HTTPS enforced · X-Frame-Options · TLS 1.3

Not Set

Content-Security-Policy · Permissions-Policy

Last scanned

Cellectis En/ 1440px